145 related articles for article (PubMed ID: 1349216)
1. Interindividual variations in enzymes controlling organophosphate toxicity in man.
Mutch E; Blain PG; Williams FM
Hum Exp Toxicol; 1992 Mar; 11(2):109-16. PubMed ID: 1349216
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
3. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).
Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants.
Vose SC; Holland NT; Eskenazi B; Casida JE
Toxicol Appl Pharmacol; 2007 Oct; 224(1):98-104. PubMed ID: 17663017
[TBL] [Abstract][Full Text] [Related]
6. Peripheral cholinesterase inhibition by occupational chlorpyrifos exposure in Australian termiticide applicators.
Dyer SM; Cattani M; Pisaniello DL; Williams FM; Edwards JW
Toxicology; 2001 Dec; 169(3):177-85. PubMed ID: 11718958
[TBL] [Abstract][Full Text] [Related]
7. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
[TBL] [Abstract][Full Text] [Related]
8. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring.
Yuknavage KL; Fenske RA; Kalman DA; Keifer MC; Furlong CE
J Toxicol Environ Health; 1997 May; 51(1):35-55. PubMed ID: 9169060
[TBL] [Abstract][Full Text] [Related]
9. Dialkylphosphorus metabolites in the urine and activities of esterases in the serum as biochemical indices for human absorption of organophosphorus pesticides.
Drevenkar V; Radić Z; Vasilić Z; Reiner E
Arch Environ Contam Toxicol; 1991 Apr; 20(3):417-22. PubMed ID: 1650168
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.
Reiner E; Radić Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688
[TBL] [Abstract][Full Text] [Related]
11. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
12. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
[TBL] [Abstract][Full Text] [Related]
13. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
14. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure.
Browne RO; Moyal-Segal LB; Zumsteg D; David Y; Kofman O; Berger A; Soreq H; Friedman A
FASEB J; 2006 Aug; 20(10):1733-5. PubMed ID: 16807370
[TBL] [Abstract][Full Text] [Related]
15. Organophosphates and monocyte esterase deficiency.
McClean E; Mackey H; Markey GM; Morris TC
J Clin Pathol; 1995 Aug; 48(8):768-70. PubMed ID: 7560207
[TBL] [Abstract][Full Text] [Related]
16. A biologic marker for organophosphate exposure: neurotoxic esterase activity in human lymphocytes and platelets.
Bleecker ML; Maroni M; Sepanski M
Dev Toxicol Environ Sci; 1983; 11():507-12. PubMed ID: 6677496
[No Abstract] [Full Text] [Related]
17. Human serum paraoxonase (PON1) activity in acute organophosphorous insecticide poisoning.
Akgür SA; Oztürk P; Solak I; Moral AR; Ege B
Forensic Sci Int; 2003 Apr; 133(1-2):136-40. PubMed ID: 12742701
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
19. The polymorphic paraoxonase/arylesterase isozymes of human serum.
La Du BN; Eckerson HW
Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
[TBL] [Abstract][Full Text] [Related]
20. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
Sogorb MA; González-González I; Pamies D; Vilanova E
Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
